Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 871 of 1,261
  1. US 8444612

    Self contained wound dressing apparatus

    Covidien LP · Granted May 21, 2013 · Expires May 16, 2033

    granted
  2. US 8445509

    Fused heterocyclic derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 21, 2013 · Expires May 16, 2033

    granted
  3. US 8445714

    Cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  4. US 8445445

    Method of promoting hair growth using FGFR4 extracellular domains

    Five Prime Therapeutics, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  5. US 8445021

    Functionalized magnetic nanoparticles and methods of use thereof

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted
  6. US 8445681

    Azaindazoles useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted May 21, 2013 · Expires May 16, 2033

    granted
  7. EP 2591003

    KREBSTHERAPIE MITTELS CLDN6-ZIELGERICHTETER ANTIKÖRPER IN VIVO

    GANYMED PHARMACEUTICALS AG [DE] · Granted May 15, 2013 · Expires May 10, 2033

    granted
  8. US 8440206

    Methods for producing an immune response to tuberculosis

    The United States of America as represented by the Department of Veteran Affairs · Granted May 14, 2013 · Expires May 9, 2033

    granted
  9. US 8440202

    Induction of an immune response against dengue virus using the prime-boost approach

    United States of America as represented by the Secretary of the Air Force · Granted May 14, 2013 · Expires May 9, 2033

    granted
  10. US 8440460

    Methods for transdifferentiating cells

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  11. US 8440210

    Stabilized pharmaceutical product

    TAKEDA GMBH · Granted May 14, 2013 · Expires May 9, 2033

    granted
  12. US 8440229

    Hollow silica nanospheres and methods of making same

    The Regents of the University of California · Granted May 14, 2013 · Expires May 9, 2033

    granted
  13. US 8440621

    Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

    The Regents of the University of California · Granted May 14, 2013 · Expires May 9, 2033

    granted
  14. US 8440689

    Fused heteroaromatic pyrrolidinones

    Takeda Pharmaceutical Company Limited · Granted May 14, 2013 · Expires May 9, 2033

    granted
  15. US 8440411

    Differential gene expression in physiological and pathological angiogenesis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

    granted
  16. US 8440652

    MST1 kinase inhibitors and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  17. US 8440692

    Hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents

    China Medical University · Granted May 14, 2013 · Expires May 9, 2033

    granted
  18. US 8440813

    Antiviral nucleoside analogs

    BioCryst Pharmaceuticals, Inc. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  19. US 8440168

    Image-guided therapy of myocardial disease: composition, manufacturing and applications

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  20. US 8440182

    Methods and compositions for treating phenylketonuria

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  21. US 8440208

    Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  22. US 8440205

    Streptococcal C5A peptidase vaccine

    Regents of the University of Minnesota · Granted May 14, 2013 · Expires May 9, 2033

    granted
  23. US 8440309

    Crosslinked polymers with the crosslinker as therapeutic for sustained release

    Covidien LP · Granted May 14, 2013 · Expires May 9, 2033

    granted
  24. US 8440393

    Pro-angiogenic genes in ovarian tumor endothelial cell isolates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.